Delayed profound thrombocytopenia associated with eptifibatide [1]

American Journal of Hematology

Volumn 81, Issue 12, 2006, Pages 984-

  Onitilo, Adedayo A ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; DOBUTAMINE; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; HEPARIN; THROMBOCYTE ANTIBODY;

AGED; CASE REPORT; DRUG WITHDRAWAL; EXERCISE TEST; HEART CATHETERIZATION; HUMAN; LETTER; LOADING DRUG DOSE; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; SPINE SURGERY; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS PREVENTION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ERYTHROCYTE TRANSFUSION; HUMANS; MALE; MYOCARDIAL ISCHEMIA; PEPTIDES; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POSTOPERATIVE COMPLICATIONS; THROMBOCYTOPENIA; THROMBOSIS; TIME FACTORS;

EID: 33845243141     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20609     Document Type: Letter

References (5)

1. Aster RH. Immune thrombocytopenia caused by glycoprotein IIb/IIIa inhibitors. Chest 2005;127:53S-59S.
2. Batchelor WB, Tolleson TR, Huang Y, et al. Randomized comparison of platelet inhibition with abciximab, tirofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide. Circulation 2002;106:1470-1476.
3. Christopoulos CG. Thrombocytopenia following treatment with platelet glycoprotein IIb/IIIa inhibitors. Blood 2003;101:1655.
4. Breth L, Kochie J, Combs A, et al. Identification and characterization of antibodies that bind GPIIb/IIIa: antagonist complexes. J Immunol Methods 2005;301:11-20.
5. Paradiso-Hardy FL, Madan M, Radhakrishnan S, Hurden S, Cohen EA. Severe thrombocytopenia possibly related to readministration of eptifibatide. Catheter Cardiovasc Interv 2001;54:63-67.